Yiming (Beijing) Cell Biotechnology Co., Ltd. announced that it has raised $30 million in funding led by Goldstone Investment Group Limited and CLSA Capital Partners on September 27, 2022. THe transaction also includes participation from BGI Co-Win, Wenzhou Capital, Finnova Capital, IDG Capital Partners Co., Ltd. and Xingtou Capital, and existing investor Beijing FOF Capital Co.,Ltd., Huagai Capital Co., Ltd.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.024 HKD | -4.00% |
|
-.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 66.47L | |
-2.79% | 12TCr | |
+3.72% | 9.57TCr | |
+26.70% | 6.83TCr | |
+8.30% | 6.52TCr | |
+16.23% | 4.52TCr | |
+14.23% | 4.31TCr | |
+23.94% | 3.72TCr | |
+6.42% | 2.56TCr | |
-4.65% | 2.23TCr |
- Stock Market
- Equities
- 901 Stock
- News Goldstone Investment Group Limited
- Yiming Cell Biotechnology Co., Ltd. announced that it has received $30 million in funding from a group of investors